文献速递衰弱、肌少症与跌倒老年综合评估

四种肌少症定义与澳大利亚老年女性死亡风险的关联

Sarcopenia Definitions and Their Associations With Mortality in Older Australian Women.
PubMed 文献 · J Am Med Dir Assoc · 2018-12-06

该前瞻性队列研究基于2003至2013年珀斯老年女性纵向研究,纳入903名社区居住老年女性(基线平均年龄79.9±2.6岁),比较四种肌少症定义与全因死亡风险的关系。结果显示EWGSOP定义及采用澳大利亚人群特定切点的AUS-POPE定义与5年和9.5年死亡风险升高相关,而FNIH和AUS-POPF定义未见此关联;握力较弱和TUG较慢与死亡风险增加相关,但ALM调整变量无此关联。

要点

  • EWGSOP和AUS-POPE定义与5年及9.5年死亡风险升高相关。
  • FNIH和AUS-POPF定义与死亡风险无显著关联。
  • 握力较弱和TUG较慢与9.5年死亡风险增加相关,ALM调整变量无关联。

核心结论

  • 包含肌力弱和/或身体功能差的EWGSOP定义及其区域适配版本与预后相关,而FNIH定义未见此关联。

研究设计与样本

  • 前瞻性队列研究,数据来自2003至2013年珀斯老年女性纵向研究,纳入903名社区居住老年澳大利亚女性,基线平均年龄79.9±2.6岁。

主要发现

  • 四种定义的肌少症基线患病率分别为FNIH 9.4%、EWGSOP 24.1%、AUS-POPF 12.0%、AUS-POPE 10.7%。
  • EWGSOP定义5年死亡aHR 1.88(95%CI 1.24‒2.85,P<.01),9.5年aHR 1.39(95%CI 1.06‒1.81,P=.02)。
  • AUS-POPE定义5年死亡aHR 2.52(95%CI 1.55‒4.09,P<.01),9.5年aHR 1.94(95%CI 1.40‒2.69,P<.01)。
  • FNIH和AUS-POPF定义与死亡风险无显著关联。
  • 握力较弱(每SD 4.9 kg,17%)和TUG较慢(每SD 3.1秒,40%)与9.5年死亡风险增加相关,ALM/ BMI或ALM/身高²调整变量无关联。

关键数值与推荐

  • FNIH、EWGSOP及采用澳大利亚年轻健康女性均值以下<2 SD切点的适配版AUS-POPF和AUS-POPE四种肌少症定义。
  • 全因死亡通过链接数据系统捕获,采用Cox比例风险模型分析5年和9.5年死亡风险。

临床怎么用

  • 在老年女性中评估肌少症时,采用包含肌力和身体功能的EWGSOP定义或其区域适配版本可能有助于识别死亡风险较高者。
  • 握力较弱和TUG较慢可作为死亡风险增加的简易预警指标,而单纯ALM调整变量关联不显著。

局限性

  • 研究仅纳入社区居住老年澳大利亚女性,结果外推至其他人群需谨慎。
  • 肌少症定义并非基于预后开发,将其用于预后评估需考虑这一背景。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To investigate the relationship of 4 sarcopenia definitions with long-term all-cause mortality risk in older Australian women. DESIGN: Data from the Perth Longitudinal Study in Aging Women from 2003 to 2013 was examined in this prospective cohort study. The 4 sarcopenia definitions were the United States Foundation for the National Institutes of Health (FNIH), the European Working Group on Sarcopenia in Older People (EWGSOP), and adapted FNIH (AUS-POPF) and EWGSOP (AUS-POPE) definitions using Australian population-specific cut-points [<2 standard deviation (SD)] below the mean of young healthy Australian women. All-cause mortality was captured via linked data systems. SETTING AND PARTICIPANTS: In total, 903 community-dwelling older Australian women (baseline mean age 79.9 ± 2.6 years) with concurrent measures of muscle strength (grip strength), physical function (timed-up-and-go; TUG) and appendicular lean mass (ALM) were included. MEASURES: Cox-proportional hazards modeling was used to examine the relationship between sarcopenia definitions and mortality over 5 and 9.5 years. RESULTS: Baseline prevalence of sarcopenia by the 4 definitions differed substantially [FNIH (9.4%), EWGSOP (24.1%), AUS-POPF (12.0%), AUS-POPE (10.7%)]. EWGSOP and AUS-POPE had increased age-adjusted hazard ratios (aHRs) for mortality over 5 years [aHR 1.88 95% confidence interval (CI) (1.24‒2.85), P < .01; aHR 2.52 95% CI (1.55‒4.09), P < .01, respectively] and 9.5 years (aHR 1.39 95% CI (1.06‒1.81), P = .02; aHR 1.94 95% CI (1.40‒2.69), P < .01, respectively). No such associations were observed for FNIH or AUS-POPF. Sarcopenia components including weaker grip strength (per SD, 4.9 kg; 17%) and slower TUG (per SD, 3.1 seconds; 40%) but not ALM adjusted-variants (ALM/body mass index or ALM/height2) were associated with greater relative hazards for mortality over 9.5 years. CONCLUSIONS/RELEVANCE: Unlike FNIH, the EWGSOP sarcopenia definition incorporating weak muscle strength and/or poor physical function was related to prognosis, as was the regionally adapted version of EWGSOP. Although sarcopenia definitions were not developed based on prognosis, this is an important consideration for globally standardizing the sarcopenia framework.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Sim M, Prince RL, Scott D, et al. Sarcopenia Definitions and Their Associations With Mortality in Older Australian Women. J Am Med Dir Assoc. 2018. PMID: 30527277. doi:10.1016/j.jamda.2018.10.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。